Armistice Capital’s Lexaria Bioscience LEXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$542K Buy
+172,084
New +$1.31M 0.01% 200
2025
Q1
– Sell
-30,667
Closed -$966K – 264
2024
Q4
$966K Buy
+30,667
New +$1.13M 0.01% 167
2024
Q3
– Sell
-68,000
Closed -$2.84M – 302
2024
Q2
$2.84M Buy
+68,000
New +$3.06M 0.04% 136
2023
Q4
– Sell
-59,285
Closed -$889K – 334
2023
Q3
$889K Buy
+59,285
New +$812K 0.01% 148

Other funds holding LEXX

Armistice Capital's LEXX Position: Q3 2026 in Review

Armistice Capital opened a new position in Lexaria Bioscience (LEXX) in Q3 2026: 172,084 shares worth $542K. The stake represents 0.01% of the portfolio and ranks #200 among its holdings. This is a return to the name: Armistice Capital previously reported a position in LEXX as recently as Q4 2024.

Armistice Capital first reported a position in LEXX in Q3 2023 and has held it in 4 quarters since. The position peaked at $2.84M in Q2 2024. 15 funds tracked by Wall St. Rank hold LEXX as of Q3 2026.

  • Armistice Capital held 172,084 shares of Lexaria Bioscience worth $542K as of Q3 2026.
  • Lexaria Bioscience was a new Armistice Capital position in Q3 2026.
  • Lexaria Bioscience made up 0.01% of Armistice Capital's portfolio in Q3 2026, its #200 holding.
  • Armistice Capital first reported a position in Lexaria Bioscience in Q3 2023 and has held it in 4 quarters since.
  • Armistice Capital's Lexaria Bioscience position peaked at $2.84M in Q2 2024.
  • 15 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2026.

Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.